A phase 1 randomized controlled trial has found an Ebola virus disease...
Novartis and Verily have helped Medicxi raise $300 million (€268 ...
Switzerland-based Ascensia Diabetes Care has entered a global technolo...
OncoSec Medical Incorporated, a company developing DNA-based intra-tum...
The National Institutes of Health has awarded researchers at Albert Ei...
Eli Lilly will acquire worldwide rights from KeyBioscience to develop ...
SciClone Pharmaceuticals has agreed to be acquired for approximately $...
The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc....
The Jackson Laboratory has signed a collaborative clinical genomics re...
Veloxis Pharmaceuticals announced that its U.S. subsidiary, Veloxis Ph...
Merck KGaA, Darmstadt, Germany, a leading science and technology compa...
The swiss drugmaker Novartis has agreed to work with IBM Watson Health...
GRAIL, Inc., a life sciences company whose mission is to detect cancer...
Cure-One, a non-profit organization dedicated to advancing precision m...
Mayo Clinic and Baxter International Inc. announced a new research and...
The University of Liverpool and Radboud University, Nijmegen have laun...
After months of testing, a hospital in Syria will have uninterrupted p...
Vetter , a leading and innovative provider of aseptic prefilled drug d...